What's happening
This bill requires the Department of Health to analyze prescription monitoring data for inappropriate prescribing of controlled substances and share findings with relevant agencies.
Why it matters
Targets Overprescribing. By specifically requiring analysis for "inappropriate prescribing of controlled substances," the bill aims to address issues like opioid overprescription, which can contribute to addiction and public health crises.
Enables Agency Action. The Department of Health must share findings with relevant agencies, potentially leading to disciplinary action against providers who violate laws or professional standards, which could improve accountability in healthcare.
Enhances Data Use. Regular analysis of prescription monitoring data means the state will use existing public health tools more proactively, potentially identifying patterns or outliers earlier and preventing harm to patients.
Improves Transparency. The requirement to keep detailed records of what information is shared, with whom, and under what authority, adds a layer of oversight and helps ensure that sensitive health data is handled responsibly.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Track Prescription Data Use
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Referred to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Monitor Prescription Data for Abuse
In Senate Committee · Health · Sponsor Michelle Hinchey
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
3447
2021-2022 Regular Sessions
IN ASSEMBLY
January 26, 2021
Introduced by M. of A. L. ROSENTHAL -- read once and referred to the Committee on Health
AN ACT to amend the public health law, in relation to department analysis of the prescription monitoring program registry
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivision 7 of section 3343-a of the public health law, as added by section 2 of part A of chapter 447 of the laws of 2012, is amended to read as follows:
7. Department analysis of data. The department shall periodically analyze data contained in the prescription monitoring program registry to identify information that indicates that a violation of law or breach of professional standards may have occurred, including the inappropriate prescribing of controlled substances and, as warranted, provide any relevant information to appropriate entities as permitted under section thirty-three hundred seventy-one of this article. The department shall keep a record of the information provided, including, but not limited to, the specific information provided and the agency to which such information was provided, including the name and title of the person to whom such information was provided and an attestation from such person that he or she has authority to receive such information.
§ 2. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD00942-01-1
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.